An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome
about
sameAs
Natural ventilation for the prevention of airborne contagionDevelopment of an empirical model to aid in designing airborne infection isolation roomsEvolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspectiveFrequency of tuberculous and non-tuberculous mycobacteria in HIV infected patients from Bogota, ColombiaTuberculosis Infection Control in Health-Care Facilities: Environmental Control and Personal ProtectionMultidrug-resistant tuberculosis in prison inmates, AzerbaijanIn vitro and in vivo activities of the benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosisOutcomes of comprehensive care for children empirically treated for multidrug-resistant tuberculosis in a setting of high HIV prevalenceReduced virulence of an extensively drug-resistant outbreak strain of Mycobacterium tuberculosis in a murine modelHuman exposure following Mycobacterium tuberculosis infection of multiple animal species in a Metropolitan ZooSimultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiologyStrain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodologyEvaluation and utilization as a public health tool of a national molecular epidemiological tuberculosis outbreak database within the United Kingdom from 1997 to 2001Evolutionary dynamics of HIV at multiple spatial and temporal scales.Practical and affordable measures for the protection of health care workers from tuberculosis in low-income countries.Multiple large clusters of tuberculosis in London: a cross-sectional analysis of molecular and spatial data.Impact of DOTS expansion on tuberculosis related outcomes and costs in HaitiHigh expression of survivin in sacral chordoma.AIDS and the lung: update 1995. 2. New developments in the pulmonary diseases affecting HIV infected individuals.Use of microsphere technology for targeted delivery of rifampin to Mycobacterium tuberculosis-infected macrophagesGenetic fingerprinting in the study of tuberculosis transmissionCost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study.Escalating threat from tuberculosis: the third epidemicLong-term molecular analysis of tuberculosis strains in alabama, a state characterized by a largely indigenous, low-risk population.Targeted hybridization of IS6110 fingerprints identifies the W-Beijing Mycobacterium tuberculosis strains among clinical isolates.New real-time PCR able to detect in a single tube multiple rifampin resistance mutations and high-level isoniazid resistance mutations in Mycobacterium tuberculosisRetrospective analysis of the Beijing family of Mycobacterium tuberculosis in preserved lung tissuesComparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis complex strains: interlaboratory study of discriminatory power and reproducibility.Evidence from molecular fingerprinting of limited spread of drug-resistant tuberculosis in TexasPathogenic clones versus environmentally driven population increase: analysis of an epidemic of the human fungal pathogen Coccidioides immitis.Spoligotyping and polymorphic GC-rich repetitive sequence fingerprinting of mycobacterium tuberculosis strains having few copies of IS6110Genetic heterogeneity in Mycobacterium tuberculosis isolates reflected in IS6110 restriction fragment length polymorphism patterns as low-intensity bands.Molecular and conventional epidemiology of Mycobacterium tuberculosis in Botswana: a population-based prospective study of 301 pulmonary tuberculosis patients.Secondary typing of Mycobacterium tuberculosis isolates with matching IS6110 fingerprints from different geographic regions of the United States.Rapid film-based determination of antibiotic susceptibilities of Mycobacterium tuberculosis strains by using a luciferase reporter phage and the Bronx Box.Efficacy of microencapsulated rifampin in Mycobacterium tuberculosis-infected micePhysiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis.Dysregulated production of interleukin-8 in individuals infected with human immunodeficiency virus type 1 and Mycobacterium tuberculosis.Antigenic equivalence of human T-cell responses to Mycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10 and to mixtures of synthetic peptides.Determinants of cluster distribution in the molecular epidemiology of tuberculosis.
P2860
Q21144681-5890C806-C73B-4347-B725-AF78A6069AAEQ23910992-9A36F13B-1E2F-4233-976C-C31703AC6D57Q24535810-661C7A4A-F825-424C-A0C7-02E455714231Q24795304-0485E147-C3DB-43A9-8AA4-9C7368052DB4Q28066470-EFAB7D23-5287-4F8C-BC4E-FFB6B7DD824EQ28366613-0A7BA4C7-609A-4AF3-9B8E-2B7C2E2D76C8Q28378826-615D02E9-B6BC-4F2D-9028-D512B1F65222Q28483868-95B23211-D31E-4294-AFA1-30B16198E294Q28537876-4A294FC7-B58B-474E-86E2-E19F9501D465Q28751715-CEA5B9E2-6E55-4B49-9AA6-09E2B9AD25CEQ29547284-7558C6BD-05D2-4CBE-899B-BE024037466AQ29614561-977D0197-F5DF-49DB-AE6B-585F26063ABAQ30332824-F55022D0-0A8C-4D4D-A223-7EA811577C94Q30416280-15D44CE3-2B10-446B-91D0-6DBF9ADE6883Q30429335-830AAACC-0911-4422-89B9-8D75FD68E6DEQ31158885-5DD8B721-7227-4A5E-95F5-90F7081E675CQ33254073-E40E2AE8-3B7F-45E5-867F-AA1B76DC3988Q33274749-D97B99A0-A4C6-436A-A32A-19E99B7AFEDCQ33604838-7AD7ED0C-6F63-4CBE-9AB1-D5CBA2C39771Q33699804-141D77E3-DC06-478C-AE60-28A87A1B6865Q33777473-C1E144B0-E552-4A58-A3CF-78880295F1C3Q33804506-2D776A89-83B0-4F1C-8B12-A9820E7D1550Q33821288-8B77EED5-4A34-4EBE-B665-51CD77B326DDQ33824674-087BDC0F-17A7-4F93-97C9-F28AAC508AF3Q33859179-7F96CA94-BBAA-4B95-8FFF-64692B889A3CQ33951187-E56C8D7B-54C7-4ED5-B26C-B284A9CAEEFDQ33958806-82AB433A-DCB1-4605-A2D6-AC9FD0B251AFQ33962045-84C6C1DB-D1F5-46C3-A877-A19CBD2B4D86Q33962974-9639D619-4961-4EA0-85F4-B9B8BCB4B0DBQ33965559-C3AB11C9-0F07-43CC-8387-0A71C3B37001Q33969871-7E56B8D2-236B-4A9D-AE7D-B723E5DE169CQ33970591-D372B488-182A-4A7A-96EF-866F1A22EDFFQ33971595-ECC1B488-B743-4C5E-99A7-7D320897F7C1Q33972149-0AF0F609-2442-4CB0-ADEA-6585F176B906Q33974669-506E65A2-4782-4BF6-816B-8829028398A2Q33976250-9FA87196-E8FD-41E9-A6A1-F7393161C45EQ33977319-61F9BB08-7198-4BCE-84D8-814ADD47CE4CQ34000599-869E8019-538C-4601-9382-F3F407C3C162Q34004667-1354204D-4371-4061-83FE-008C362DE465Q34010114-89B0D68C-FB42-4B14-BA56-C718A44757C6
P2860
An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
An outbreak of multidrug-resis ...... ired immunodeficiency syndrome
@ast
An outbreak of multidrug-resis ...... ired immunodeficiency syndrome
@en
An outbreak of multidrug-resis ...... ired immunodeficiency syndrome
@nl
type
label
An outbreak of multidrug-resis ...... ired immunodeficiency syndrome
@ast
An outbreak of multidrug-resis ...... ired immunodeficiency syndrome
@en
An outbreak of multidrug-resis ...... ired immunodeficiency syndrome
@nl
prefLabel
An outbreak of multidrug-resis ...... ired immunodeficiency syndrome
@ast
An outbreak of multidrug-resis ...... ired immunodeficiency syndrome
@en
An outbreak of multidrug-resis ...... ired immunodeficiency syndrome
@nl
P2093
P921
P3181
P1476
An outbreak of multidrug-resis ...... ired immunodeficiency syndrome
@en
P2093
E M Sordillo
J I Tokars
J O Kilburn
J T Crawford
J Williams
K G Castro
M H Grieco
S W Dooley
P304
P3181
P356
10.1056/NEJM199206043262302
P407
P50
P577
1992-06-04T00:00:00Z